1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Biomerica Launches New Patented Test to Identify Individuals at Risk of … – MarketWatch (press release)

January 31, 2012Immunosuppressive Drugsadmin

Biomerica Launches New Patented Test to Identify Individuals at Risk of ...
MarketWatch (press release)
The most commonly used thiopurine drug is called azathioprine. It is estimated that one in every 300 people lacks TPMT, which is an enzyme that helps remove thiopurine drugs from the body when they are present. Individuals who lack the TPMT enzyme can ...

and more »

Post navigation

← Bieber Supports Organ Donation Through Twitter – I on Stratford Immunomedics Awarded Broad Patent for Anti-CD20 and Anti-CD22 Combination Therapy – MarketWatch (press release) →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos